Document is current
Any future updates will be listed below
-
Authors
Kim, Hyoungyoung
Cho, Soo-Kyung
Song, Yeo-Jin
Kang, Juyeon
Jeong, Seung-A
Kim, Hye Won
Choi, Chan-Bum
Kim, Tae-Hwan
Jun, Jae-Bum
Bae, Sang-Cheol
Yoo, Dae-Hyun
Lee, Hyun
Park, Dong Won
Sohn, Jang Won
Yoon, Ho Joo
Hong, Su Jin
Yoo, Seung-Jin
Choi, Yo Won
Lee, Youkyung
Kim, Sang Heon
Sung, Yoon-Kyoung http://orcid.org/0000-0001-6691-8939
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
JW Pharmaceuticals
Basic Science Research Program of the National Research Foundation of Korea (NRF-2021R1A6A1A03038899)
- License Information
-
More Information
Article History
Received: 12 September 2022
Accepted: 28 February 2023
First Online: 17 March 2023
Declarations
:
: This study complies with the Declaration of Helsinki; the institutional review board (IRB) of Hanyang University Hospital for Rheumatic Diseases [IRB file no. HYUH 2016-06-019] has approved the research protocol; and written informed consent has been obtained from the participants (or their legally authorized representatives). This study has been registered in the U.S. ClinicalTrials.gov database (no. NCT03099525).
: Not applicable.
: YK Sung has received research grants from Bristol-Myers Squibb, Eisai, Pfizer, and JW Pharmaceuticals. The other authors have no conflicts of interest.
